CAS 163521-08-2: 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1)
Formula:C26H27N5O2·ClH
InChI:InChI=1S/C26H27N5O2.ClH/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32;/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32);1H
InChI key:InChIKey=RPZBRGFNBNQSOP-UHFFFAOYSA-N
SMILES:C(CCCN1CCN(CC1)C=2C=C3C(=CC2)OC(C(N)=O)=C3)C=4C=5C(NC4)=CC=C(C#N)C5.Cl
Synonyms:- 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1)
- 2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, monohydrochloride
- Emd-68843
- Sb-659746A
- Viibryd
- Vilazodone HCl
- Vilazodone Intermediate 2
- Vilazodone hydrochloride
Sort by
Found 14 products.
Vilazodone Hydrochloride
CAS:Vilazodone Hydrochloride (EMD 68843) , a partial agonist of 5-HT1A receptors and specific serotonin reuptake inhibitor (SSRI), is utilized in treating of theFormula:C26H27N5O2·HClPurity:100% - 99.56%Color and Shape:SolidMolecular weight:477.99Vilazodone Hydrochloride
CAS:Formula:C26H27N5O2·HClPurity:>98.0%(HPLC)Color and Shape:White to Light yellow powder to crystalMolecular weight:477.992-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1)
CAS:Formula:C26H28ClN5O2Purity:98%Color and Shape:SolidMolecular weight:477.98585-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride
CAS:Controlled ProductVilazodone is a serotonin reuptake inhibitor and 5-HT1A receptor agonist that has been shown to be effective in the treatment of major depressive disorder. It interacts with other drugs, such as dopamine, which may lead to side effects. Vilazodone is metabolized by CYP2D6 and CYP3A4 enzymes and inhibitors of these enzymes may increase vilazodone levels, while inducers of these enzymes may decrease vilazodone levels. Vilazodone also inhibits the hepatic cytochrome P450 enzyme system and should not be used in patients with hepatic impairment or liver disease. Patients with autoimmune diseases should avoid using vilazodone because it may worsen the condition or cause new symptoms.Formula:C26H27N5O2·HClPurity:Min. 95%Color and Shape:PowderMolecular weight:477.99 g/molVilazodone Hydrochloride
CAS:Controlled ProductFormula:C26H27N5O2·ClHColor and Shape:NeatMolecular weight:477.99Vilazodone HCl
CAS:Formula:C26H27N5O2·HClColor and Shape:White To Off-White SolidMolecular weight:441.54 36.46
![2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA001U74.jpg&w=3840&q=75)
![5-[4-[4-(5-Cyanoindol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide hydrochloride](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FFC59658.jpg&w=3840&q=75)
